Dr. Ervin Szoke
I've won the following awards
Scholars in Endocrinology, Pfizer
Milwaukee Lifestyle Magazine Top Doctor 2013
Different pathophysiology of impaired glucose tolerance in first-degree relatives of individuals with type 2 diabetes mellitus.
Metab. Clin. Exp., May;58(5):602-7 (2009)
Effect of aging on glucose homeostasis: accelerated deterioration of beta-cell function in individuals with impaired glucose tolerance.
Diabetes Care., Mar;31(3):539-43 (2008)
Different mechanisms for impaired fasting glucose and impaired postprandial glucose tolerance in humans.
Diabetes Care., Aug;29(8):1909-14 (2006)
Multiple defects in counterregulation of hypoglycemia in modestly advanced type 2 diabetes mellitus.
Metab. Clin. Exp., May;55(5):593-8 (2006)
Effects of glimepiride and glyburide on glucose counterregulation and recovery from hypoglycemia.
Metab. Clin. Exp., Jan;55(1):78-83 (2006)
Increasing the decrement in insulin secretion improves glucagon responses to hypoglycemia in advanced type 2 diabetes.
Diabetes Care., Nov;28(11):2691-6 (2005)
Mechanisms for abnormal postprandial glucose metabolism in type 2 diabetes.
Am. J. Physiol. Endocrinol. Metab., Jan;290(1):E67-E77 (2006)
Role of impaired insulin secretion and insulin resistance in the pathogenesis of type 2 diabetes mellitus.
Compr Ther., 31(2):106-12 (2005)
Role of the decrement in intraislet insulin for the glucagon response to hypoglycemia in humans.
Diabetes Care., May;28(5):1124-31 (2005)
Diagnostic and therapeutic implications of relationships between fasting, 2-hour postchallenge plasma glucose and hemoglobin a1c values.
Arch. Intern. Med., 164(15):1627-32 (2004 Aug 9-23)